"The number one advantage regarding Nevisense is that it backs up my decision and provides me with more certainty in whether or not to excise a lesion"Dr. Isabel Gahlen, Ludwigsburg, Germany
Extraordinary General Meeting April 29, 2020 : Special Procedure Due To The Spread Of CoronavirusApril 8, 2020SPECIAL PROCEDURE DUE TO THE SPREAD OF CORONAVIRUS In light of the spread of the coronavirus, the board of directors has decided to implement certain precautionary measures for the extraordinary general meeting on 29 April 2020 in order to ascertain the well-being of the company’s shareholders’ as well as the opportunity for them to exercise […]
Comments on Covid-19The consequences of the Covid19 outbreak have started to affect SciBase from mid-March, and there is a high risk that these could lead to a significant financial impact on the Group. However, the effects are very difficult to predict, and the situation is constantly changing. First and foremost, we at SciBase are working to ensure […]
SciBase publishes the Annual report for 2019April 3, 2020
SciBase hereby announces that the Annual report for 2019 is available at the Company's website www.scibase.com.
- Load more news...